Phylos Overview

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.52M

  • Investors
  • 15

Phylos General Information

Description

Operator of an agricultural genomics company intended to enhance the next generation of hemp and cannabis. The company offers a suite of tools using modern molecular genetics and computational biology to provide breeding and research services, enabling cannabis growers and cultivators to understand the breadth of genetics in their catalog, evaluate the development of additional varieties and drive business growth.

Contact Information

Website
www.phylos.bio
Formerly Known As
Phylos Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2455 NorthWest Nicolai Street
  • Suite B-O6
  • Portland, OR 97210
  • United States
+1 (503)
Primary Industry
Other Agriculture
Vertical(s)
Corporate Office
  • 2455 NorthWest Nicolai Street
  • Suite B-O6
  • Portland, OR 97210
  • United States
+1 (503)

Phylos Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phylos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 15-Jan-2025 $4.52M Completed Generating Revenue
9. Later Stage VC 01-Feb-2022 Completed Generating Revenue
8. Later Stage VC 04-May-2021 Completed Generating Revenue
7. Later Stage VC 26-Jan-2021 Completed Generating Revenue
6. Later Stage VC (Series B1) 29-Apr-2020 Completed Generating Revenue
5. Later Stage VC (Series C) 15-Jan-2019 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Later Stage VC (Series B) 17-Jan-2014 Completed Generating Revenue
2. Early Stage VC (Series A1) 30-Mar-2011 $1000K $2.4M Completed Startup
1. Early Stage VC (Series A) 14-Nov-2008 $1.4M $1.4M Completed Startup
To view Phylos’s complete valuation and funding history, request access »

Phylos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A1 109,811 $19.93 $19.93 $19.93 12.9%
Series A 355,716 $19.93 $19.93 $19.93 41.79%
To view Phylos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phylos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an agricultural genomics company intended to enhance the next generation of hemp and cannabis. The company o
Other Agriculture
Portland, OR
50 As of 2024

Windsor, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phylos Competitors (1)

One of Phylos’s competitors is New West Genetics, a Venture Capital-Backed company based in Windsor, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
New West Genetics Venture Capital-Backed Windsor, CO
You’re viewing 1 of 1 competitors. Get the full list »

Phylos Patents

Phylos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240381800-P1 Cannabis plant named 'ptc8506v' Pending 23-Apr-2024
US-PP35172-P2 Cannabis plant named ‘pct11204v’ Active 11-Mar-2022
EP-4462991-A1 Hermaphroditism markers Pending 11-Jan-2022
US-20240341254-A1 Varin profiles Pending 14-Oct-2021
US-20250127104-A1 Cannabinoid markers Pending 29-Sep-2021 A01H1/04
To view Phylos’s complete patent history, request access »

Phylos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phylos Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
OrganiGram Holdings Corporation
The Arcview Group Angel Group Minority
Accomplice VC Venture Capital Minority
Merida Capital Holdings Growth/Expansion Minority
Arcadian Capital Growth/Expansion Minority
You’re viewing 5 of 15 investors. Get the full list »

Phylos FAQs

  • Where is Phylos headquartered?

    Phylos is headquartered in Portland, OR.

  • What is the size of Phylos?

    Phylos has 50 total employees.

  • What industry is Phylos in?

    Phylos’s primary industry is Other Agriculture.

  • Is Phylos a private or public company?

    Phylos is a Private company.

  • What is Phylos’s current revenue?

    The current revenue for Phylos is .

  • How much funding has Phylos raised over time?

    Phylos has raised $45.7M.

  • Who are Phylos’s investors?

    OrganiGram Holdings, The Arcview Group, Accomplice VC, Merida Capital Holdings, and Arcadian Capital are 5 of 15 investors who have invested in Phylos.

  • Who are Phylos’s competitors?

    New West Genetics is a competitor of Phylos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »